Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-22

FDA Approved: NEVIRAPINE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan Pharmaceuticals' original application for Nevirapine as a generic treatment for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

ORIG AP for NEVIRAPINE (NEVIRAPINE)